Semaglutide is a GLP-1 classification drug for Diabetes. It is an injectable medication used for the treatment of chronic weight management in adults with an initial body mass index (BMI) that is considered outside a healthy range. Semaglutide is not FDA approved for weight loss management, but is being administered as an “off-label” treatment. Consultation is required.